Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

Description

The objective of the study is to determine the effectiveness of postoperative Tamsulosin in reducing the duration of acute postoperative urinary retention (POUR) following pelvic reconstructive surgery through a double blind, randomized placebo-controlled trial.

Conditions

Urinary Retention Postoperative

Talk to us

Study Overview

On this page

Study Details

Study overview

The objective of the study is to determine the effectiveness of postoperative Tamsulosin in reducing the duration of acute postoperative urinary retention (POUR) following pelvic reconstructive surgery through a double blind, randomized placebo-controlled trial.

The Impact of Tamsulosin on Duration of Post-Operative Urinary Retention in Women Undergoing Pelvic Reconstructive Surgery- A Double Blind, Randomized, Placebo-Controlled Study

Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

Condition
Urinary Retention Postoperative
Intervention / Treatment

-

Contacts and Locations

Pittsburgh

West Penn Hospital, Pittsburgh, Pennsylvania, United States, 15224

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years or older
  • * willing and able to provide informed consent
  • * postoperative urinary retention as defined by a failed RGVT prior to hospital discharge
  • * Ability to speak and read English
  • * Tolerate pill ingestion
  • * allergy/intolerance to Tamsulosin or sulfa drugs
  • * preoperative history of urinary retention as defined by preoperative post void residual of \>150mL
  • * current use of alpha antagonist medication for hypertension
  • * severe dementia
  • * end stage renal or liver disease
  • * history of severe heart failure or major cardiovascular event in the last 6 months

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute),

Lindsay Turner, MD, PRINCIPAL_INVESTIGATOR, Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Study Record Dates

2025-12